Faculty, Staff and Student Publications
Publication Date
1-8-2025
Journal
Blood Cancer Discovery
DOI
10.1158/2643-3230.BCD-24-0171
PMID
39565177
PMCID
PMC11707511
PubMedCentral® Posted Date
11-20-2024
PubMedCentral® Full Text Version
Post-print
Abstract
In recent years, there has been tremendous interest surrounding the integration of venetoclax into both non-intensive and intensive chemotherapy regimens for AML. However, with this increasing utilization of venetoclax, considerable questions surrounding key issues such as dosing strategies and the practicality of venetoclax administration have arisen. This review highlights the evolution of venetoclax-based regimens in AML and provides a commentary on notable practical considerations when utilizing this agent.
Keywords
Bridged Bicyclo Compounds, Heterocyclic, Sulfonamides, Humans, Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents
Published Open-Access
yes
Recommended Citation
Goulart, Hannah; Kantarjian, Hagop; Pemmaraju, Naveen; et al., "Venetoclax-Based Combination Regimens in Acute Myeloid Leukemia" (2025). Faculty, Staff and Student Publications. 4353.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4353
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons